Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk Neuroblastoma
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Neuroblastoma
Related studies linked through entity extraction aliases.
ZD6474 Alone and in Combination With Retinoic Acid in Pediatric Neuroblastoma
- Status
- TERMINATED
- Phase
- PHASE1
Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma
- Status
- UNKNOWN
- Phase
- NA
N2004-06: Irinotecan and Vincristine With 131I-MIBG Therapy for Resistant/Relapsed High-Risk Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Enzastaurin in Treating Young Patients With Refractory Primary CNS Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE3
Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of Nifurtimox for Relapsed or Refractory Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Ethanol-Lock Treatment in Preventing Central Venous Catheter Infections in Patients With High-Risk Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Iodine I 131 Monoclonal Antibody 3F8 and Bevacizumab in Treating Patients With Relapsed or Refractory Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Monoclonal Antibody 3F8 and GM-CSF in Treating Young Patients With High-Risk, Refractory or Relapsed Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
HGS-ETR2 to Treat Children With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma Who Are Undergoing Surgery With or Without Autologous Bone Marrow or Peripheral Stem Cell Transplant
- Status
- UNKNOWN
- Phase
- PHASE3
Combination Chemotherapy and Surgery With or Without Radiation Therapy in Treating Patients With Stage 2 or Stage 3 Neuroblastoma
- Status
- UNKNOWN
- Phase
- PHASE3
Observation of Young Patients With Localized Neuroblastoma Who Have Undergone Surgery Only
- Status
- UNKNOWN
- Phase
- PHASE2
Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma
- Status
- UNKNOWN
- Phase
- PHASE3
Clinical Studies of Gemcitabine-Oxaliplatin
- Status
- COMPLETED
- Phase
- PHASE2